272 related articles for article (PubMed ID: 11591738)
1. Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line.
Maeda M; Lohwasser S; Yamamura T; Takei F
J Immunol; 2001 Oct; 167(8):4180-6. PubMed ID: 11591738
[TBL] [Abstract][Full Text] [Related]
2. MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.
Sköld M; Stenström M; Sidobre S; Höglund P; Kronenberg M; Cardell S
Immunology; 2003 Nov; 110(3):313-21. PubMed ID: 14632658
[TBL] [Abstract][Full Text] [Related]
3. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of Ly49 expression on CD4+ and CD4-CD8- (double negative) NK1.1+ T cells.
Sköld M; Cardell S
Eur J Immunol; 2000 Sep; 30(9):2488-96. PubMed ID: 11009081
[TBL] [Abstract][Full Text] [Related]
5. Natural killing of MHC class I(-) lymphoblasts by NK cells from long-term bone marrow culture requires effector cell expression of Ly49 receptors.
Lindberg J; Martín-Fontecha A; Höglund P
Int Immunol; 1999 Aug; 11(8):1239-46. PubMed ID: 10421781
[TBL] [Abstract][Full Text] [Related]
6. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
7. Control of NKT cell differentiation by tissue-specific microenvironments.
Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
[TBL] [Abstract][Full Text] [Related]
8. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells.
Fahlén L; Lendahl U; Sentman CL
J Immunol; 2001 Jun; 166(11):6585-92. PubMed ID: 11359811
[TBL] [Abstract][Full Text] [Related]
9. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
10. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
[TBL] [Abstract][Full Text] [Related]
11. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.
Inui T; Nakagawa R; Ohkura S; Habu Y; Koike Y; Motoki K; Kuranaga N; Fukasawa M; Shinomiya N; Seki S
J Immunol; 2002 Dec; 169(11):6127-32. PubMed ID: 12444115
[TBL] [Abstract][Full Text] [Related]
12. Thymus-dependent modulation of Ly49 inhibitory receptor expression on NK1.1+gamma/delta T cells.
Hara T; Nishimura H; Hasegawa Y; Yoshikai Y
Immunology; 2001 Jan; 102(1):24-30. PubMed ID: 11168633
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
14. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire.
Held W; Dorfman JR; Wu MF; Raulet DH
Eur J Immunol; 1996 Oct; 26(10):2286-92. PubMed ID: 8898935
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
[TBL] [Abstract][Full Text] [Related]
17. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire.
Held W; Kunz B
Eur J Immunol; 1998 Aug; 28(8):2407-16. PubMed ID: 9710218
[TBL] [Abstract][Full Text] [Related]
18. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells.
Held W; Roland J; Raulet DH
Nature; 1995 Jul; 376(6538):355-8. PubMed ID: 7630404
[TBL] [Abstract][Full Text] [Related]
19. Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures.
Das A; Saxena RK
Immunol Lett; 2004 Jul; 94(3):209-14. PubMed ID: 15275968
[TBL] [Abstract][Full Text] [Related]
20. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
